Molecular Pathogenesis and Therapy of Polycythemia Induced in Mice by JAK2 V617F
Virginia M. Zaleskas(Molecular Oncology (United States)), Richard A. Van Etten(University of California, Irvine)
Cited by 215
Related Papers
Tyrosine Kinases as Targets for Cancer Therapy
|New England Journal of Medicine|2005|1.4k
Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy
|bioRxiv (Cold Spring Harbor Laboratory)|2022|3